Schistosomiasis is the second most important parasitic disease in the world in terms of public health impact. Globally, it is estimated that the disease affects over 200 million people and is responsible for 200,000 deaths each year. The three major schistosomes infecting humans are Schistosoma mansoni, S. japonicum, and S. haematobium. Much immunological research has focused on schistosomiasis because of the pathological effects of the disease, which include liver fibrosis and bladder dysfunction. This unit covers a wide range of aspects with respect to maintaining the life cycles of these parasites, including preparation of schistosome egg antigen, maintenance of intermediate snail hosts, infection of the definitive and intermediate hosts, and others. The unit primarily focuses on S. mansoni, but also includes coverage of S. japonicum and S. haematobium life cycles.

Download full-text PDF

Source
http://dx.doi.org/10.1002/0471142735.im1901s103DOI Listing

Publication Analysis

Top Keywords

japonicum haematobium
8
life cycles
8
schistosomiasis schistosomiasis
4
schistosomiasis second
4
second parasitic
4
parasitic disease
4
disease terms
4
terms public
4
public health
4
health impact
4

Similar Publications

Background: Schistosomiasis, a neglected tropical disease, affects approximately 40 million women of reproductive age contributing to preventable anaemia during pregnancy, intrauterine growth retardation and low birth weight. In spite of the high prevalence rate of this disease among school aged children in Abakaliki, no study in Abakaliki has looked at the burden of Schistosomal infection in pregnancy with a view to determining maternal and neonatal outcomes.

Objective: To determine the association between schistosomal infection and maternal anemia, low birth weight, and other neonatal outcomes in Abakaliki.

View Article and Find Full Text PDF
Article Synopsis
  • * In 2019, approximately 236.6 million people required treatment for schistosomiasis, highlighting its significant impact on fishing and agricultural communities.
  • * The Vaccine Value Profile (VVP) is a comprehensive assessment created by a group of experts to evaluate the public health and economic potential of new vaccines targeting schistosomiasis, emphasizing the need to address existing research gaps.
View Article and Find Full Text PDF

Schistosomiasis Chemotherapy, Chemoprevention, and Vaccines: History, Progress, and Priorities.

Immun Inflamm Dis

November 2024

Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour, AlBeheira, Egypt.

Article Synopsis
  • * The transmission of this disease requires freshwater snails and human contact with contaminated water, with no effective vaccines currently available despite ongoing research into potential candidates.
  • * Praziquantel (PZQ) is a key medication for treating schistosomiasis, but its widespread use has raised concerns about drug resistance, while reinfection in high-risk areas and immature worms limit its effectiveness, highlighting the urgent need for a vaccine.
View Article and Find Full Text PDF

A Recent Advance in the Diagnosis, Treatment, and Vaccine Development for Human Schistosomiasis.

Trop Med Infect Dis

October 2024

Marwadi University Research Center, Department of Microbiology, Faculty of Sciences, Marwadi University, Rajkot 360003, Gujarat, India.

Article Synopsis
  • * The disease is caused by several species of schistosomes and can result in two forms: intestinal and urogenital, with both involving co-infections that complicate treatment and outcomes; women are particularly at risk due to exposure to contaminated water during daily activities.
  • * The primary treatment is Praziquantel, but it doesn’t prevent re-infections; ongoing research aims to improve schistosomiasis diagnosis through molecular techniques and develop vaccines, focusing on
View Article and Find Full Text PDF

Schistosomiasis-Microbiota Interactions: A Systematic Review and Meta-Analysis.

Pathogens

October 2024

Biomedical and Clinical Research Centre, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana.

Introduction: Schistosomiasis, a tropical disease affecting humans and animals, affected 251.4 million people in 2021. , , , and are primary human schistosomes, causing tissue damage, granulomas, ulceration, hemorrhage, and opportunistic pathogen entry.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!